COVID-19 vaccine Sputnik V shows 92% efficacy, says Russia
Published
Results are based on an analysis of 20 participants in phase 3 trial
Full ArticlePublished
Results are based on an analysis of 20 participants in phase 3 trial
Full ArticleThe Russian Direct Investment Fund (RDIF) and Hetero, one of India's generic pharmaceutical companies, have agreed to produce in..